"Health data represents one of the most valuable types of personal data available to companies, whether this be for the training of AI (it is worth noting that the AI health care market is estimated to reach a value of around $187bn by 2030, the development of digital health technology (such as wearables, estimated to be valued at around $76bn by 2030)"
"These actions are not only impactful for affected data subjects, but are gaining popularity among commercial law firms and litigation investors, who view the cases as lucrative investment opportunities given the huge amounts of money companies may have to pay when they lose, a portion of which is typically given to the lawyers or investors supporting the affected data subjects."
Health data has become exceptionally valuable to companies for AI training, digital health products and targeted advertising, with markets projected to reach tens to hundreds of billions by 2030. Certain health signals, such as pregnancy data, can be far more valuable to advertisers than basic demographics. Corporate control over sensitive health data creates power imbalances and makes individual redress difficult, leaving data subjects feeling powerless and exposed. US class actions are emerging as a mechanism to seek redress for exploitation of health data, attracting law firms and litigation investors because large damages awards can force companies to alter practices or pay substantial compensation.
Read at Privacy International
Unable to calculate read time
Collection
[
|
...
]